IgA nephropathy: who works on it

One card per institution. Pick a target or a country to narrow the list.

• All targets
• BCMA 7
• CD19 8
• SGLT2 1
• CD20 0
• CD38 0
• IL-6 0
• JAK 0
• NLRP3 0
• TLR4 0
• mTOR 0
• STING 0
• IL-17 0
• AKT 0
• AMPK 0
• EGFR 0
• FAK 0
• GPX4 0
• HER2 0
• IL-1 0
• MET 0
• MYC 0
• NRF2 0
• PD-1 0
• PI3K 0
• STAT3 0
• TP53 0

1 of 1+ institutions, ordered by recent publications and open trials. This is not a ranking of quality.

Funded research projects that name this disease in their title, terms or summary and have not ended yet: who is funded, where, how much and until when. Organisations only; the funder's page has the details.

• NIH NIDDK · F32

  Biomarkers for Thrombotic Risk Stratification in Nephrotic Syndrome

  Children's Hosp of Philadelphia· Philadelphia, United States· US$86,824 awarded in fiscal year 2026· until Sept 2027

• NIH NIAID · R56

  Regulatory T Cell Dysfunction as a Biomarker for Personalized Therapeutic Target Identification in SLE

  Weill Medical Coll of Cornell Univ· New York, United States· US$647,571 awarded in fiscal year 2026· until Aug 2027

• NIH NIDDK · R01

  Determination of structural features critical for nephritogenic properties of IgA1-containing immune complexes in IgA nephropathy

  University of Alabama at Birmingham· Birmingham, United States· US$743,278 awarded in fiscal year 2026· until May 2030

• NIH NIAID · R43

  Precision CAR-NK therapy for VK4-1 autoreactive B cells in autoimmune diseases: advancing treatment with preserved immune function.

  Celdara Medical, Llc· Lebanon, United States· US$320,863 awarded in fiscal year 2026· until Aug 2027

• NIH NIAID · R21

  Group A Streptococcus induced autoimmune complexes

  University of Alabama at Birmingham· Birmingham, United States· US$223,500 awarded in fiscal year 2026· until Aug 2028

• European Commission (Horizon Europe) · HORIZON-ERC

  Role of CD1c-reactive T cells and lipid antigens in post-streptococcal disease (CReativeLipid)

  The Chancellor, Masters and Scholars of the University of Oxford· Oxford, United Kingdom· EU contribution €1,491,316· until Sept 2030

  The disease is named only in the funder's project summary, not in the title.

• European Commission (Horizon Europe) · HORIZON-ERC

  Antigen-specific treatments to target autoimmune kidney diseases (AUTO-TARGET)

  Universitaetsklinikum Hamburg-Eppendorf· Hamburg, Germany· EU contribution €1,499,663· until Mar 2030

• European Commission (Horizon Europe) · HORIZON-RIA

  Gene-edited T cells combating IgA Nephropathy. A blueprint approach for safe & efficient genome editing of T cells to sustainably combat several immune diseases and cancers related to B-cell pathology (geneTIGA)

  Charite - Universitaetsmedizin Berlin· Berlin, Germany· EU contribution €6,393,734· until Dec 2026· 8 countries

8 of 129 running projects, newest first. Listed amounts together: US$70.6m + €9.4m.

Sources: NIH RePORTER (U.S. National Institutes of Health, public domain) and CORDIS (European Commission, CC BY 4.0). Changes: filtered by disease, organisations matched to ROR.

Trials whose registry record says individual participant data (IPD) will be shared.

• A Study to Investigate Safety and Effect of Sparsentan in Combination With SGLT2 Inhibition in Participants With IgAN

  NCT05856760· Travere Therapeutics, Inc.· Source

• Multicentre Clinical Study to Evaluate the Effect of Personalized Therapy on Patients With Immunoglobulin A Nephropathy.

  NCT04662723· Fondazione Schena· Source

Find publications on this disease by a MeSH method term, for example a sequencing or imaging method.

• Single-Cell Analysis 6
• Mendelian Randomization Analysis 14
• Gene Expression Profiling 14
• Proteomics 8
• Metabolomics 5
• Flow Cytometry 2
• Immunohistochemistry 4
• Magnetic Resonance Imaging 1
• Machine Learning 9
• Deep Learning 3
• Cohort Studies 14
• Genome-Wide Association Study 20

• Association of Renal CD68+ Cell Infiltration with Oxford Classification in IgA Nephropathy.

  Iran J Kidney Dis, Jul 2026

• A nine-gene diagnostic model for IgA nephropathy based on multi-cohort machine learning: integrating gene expression and immunohistochemical validation.

  Ren Fail, Mar 2026

• Predictive value of interstitial inflammation for renal outcome in patients with immunoglobulin a nephropathy.

  Immunobiology, Dec 2025

• [Effects of astragalus on renal tubulointerestitial lesions and expression of NF-kappaB and MCP-1 in renal tissues in rat experimental IgA nephropathy].

  Zhongguo Dang Dai Er Ke Za Zhi, Apr 2008

See which targets of this disease your abstract mentions, and go to the people working on them.